A systematic series of chemically modified coumarin dimmers has been synthesized and tested for their inhibitory activity against HIV-1 integrase. We observed that modified coumarin dimmers containing hydrophobic moiety on the linker display potent inhibitory activities.
Integration of reversely transcribed viral DNA of the human immunodeficiency virus type 1 into chromosomal DNA of newly infected cells is an essential step of the viral replicative cycle. HIV-1 integrase (HIV-1 IN) is responsible for the integration. This enzyme catalyzes two reactions referred to as 3Ј-processing (cleavage of a dinucleotide from each end of viral DNA) and strand transfer (insertion of the viral DNA into the host cellular DNA). [1] [2] [3] Because the integration process is essential for the replication of HIV and the enzyme appears to be absent in the mammalian host, HIV-1 IN represents a potential target for the development of nontoxic antiviral therapeutic agents. 4, 5) Systematic screening of potential inhibitors has been undertaken using mostly purified integrase-based assays. From such screens several integrase inhibitor classes have now been identified. [6] [7] [8] [9] [10] The tetrameric 4-hydroxycoumarin (NSC 158393, I) was first reported against HIV-1 IN by Mazumder et al. 11) with potent inhibition of both 3Ј-processing (IC 50 ϭ1.5 mM) and strand transfer (IC 50 ϭ0.8 mM). In order to delineate structural features of NSC 158393 necessary for high inhibitory activity, Zhao et al. 12) disclosed the minimum active pharmacophore (II), i.e. a coumarin dimmer containing an aryl substituent on the central linker methylene. We also recently reported 4-hydroxycoumarin dimmers bearing aniline mustard moiety (III) 13) and reasoned the mustard moiety might react with nearby nucleophile of the coumarin-IN complex binding site to form a covalent bonding and to improve the inhibitory activity. However, these compounds seem to fail forming covalent binding at coumarin-IN complex binding site because the compounds with the appending of aniline mustard did not markedly increase the inhibitory activity. This finding indicates a probably non-nucleophile or hydrophobic region at the coumarin-IN complex binding site. Therefore we pay our efforts on the synthesis of coumarin dimmer appending with hydrophobic moiety (IV). In this report, we describe the synthesis of chemically modified coumarin dimmer analogues and their inhibitory activity on HIV-1 IN.
Chemistry
The synthetic route to the target compounds (2), (4a-f) and (6a-e) are outlined in Chart 1. Starting 4-hydroxybenzaldehyde was transformed to their corresponding 4-(2-hydroxyethoxy)benzaldehyde (1), alkyl-and aryl-sulfonyloxybenzaldehyde (3a-f), and arylcarbonyloxybenzaldehyde (3a-e) by using 2-chloroethanol, alkyl-and aryl-sulfonyl chloride, and 4-substituted benzoyl chloride, respectively. Subsequent coupling with 4-hydroxycoumarin provided target compounds (2), (4a-f) and (6a-e) in moderate to high yield.
Results and Discussion
HIV-1 IN inhibition assays were carried out in the presence of low amounts of purified recombinant integrase (50 nM) in the presence of 7.5 mM Mg 2ϩ as the cationic cofactor, using 21-mer double-strand oligonucleotide substrate. The compounds were screened for their inhibitory activity in a 3Ј-processing assay which was performed as described previously. 14) Effects against the strand transfer activity were evaluated during the same assay from the homologous integration events and found to be no significant differences from 3Ј-processing inhibition, thus confirming that coumarins affect equally both steps of the integration reaction. The inhibitory effects of 3Ј-processing are summarized in Table 1 . All compounds tested were found to have good to potent HIV-1 IN inhibitory activity against the recombinant wild-type enzyme. The inhibitory activity of NSC 158393 (I) and II were included for a comparison. On the basis of their structure, the compounds tested can be roughly classified as (A), compounds with aryl-substituted attached on the benzoyloxy-or sulfonyloxy-linker (4b-f, 6a-e) and (B), compounds without aryl-substituted attached on the linker (2, 4a). Class A compounds exhibited potent inhibitory activity with IC 50 value in the range of 0.5-3.9 mM. Their inhibitory activities were superior to II and comparable to NSC 158393 (I). However, Class B compounds showed moderate to non inhibitory activity with IC 50 value 23.7 and Ͼ100 mM, respectively. It is of interest to note: First that compounds with an aryl-substituted linker (4b-f, 6a-e) possessed higher inhibitory activity than compounds without this substitution (2, 4a); And second, that a benzoyloxy-or sulfonyloxy-linker seemed necessary for the inhibitory activity since compounds 2 devoid of benzoyloxy or sulfonyloxy linkage did not show any activity. Based on this observation, we postulate that an interaction formed between a hydrophobic surface located in the close vicinity of the coumarin-IN complex binding site and the aromatic moiety linked to coumarin molecule is important for strengthening the anchorage of the active compound. However, this assumption needs further verification.
In conclusion, twelve new chemically modified coumarin dimmer analogues have been synthesized. Among these easily available coumarin dimmers, ten were found to be active molecules against HIV-1 IN. These active molecules all contain hydrophobic moiety on the linker, which might have some contribution on the inhibitory activity. This finding may be useful in future studies concerned with the development of potent new HIV-1 IN inhibitors.
Experimental
General Melting points (mp) were taken on a BUCHI 530 apparatus and are uncorrected. Merck Art No105554 plates precoated with Silica gel 60 containing fluorescent indicator were used for thin-layer chromatography, and Silica gel 60 (Merck Art No 109385, 230-400 mesh) was employed for column chromatography. Evaporations were carried out at Ͻ50°C using a rotary evaporator at reduced pressure (water aspirator).
1 H-and 13 C-NMR spectra were obtained at Varian 300 NMR spectrometer at 300 and 75 MHz, respectively. Where necessary, deuterium exchange experiments were used to obtained proton shift assignments. Mass spectra were recorded on a JEOL J.M.S-300 spectrophotometer. Analytical samples were dried under reduced pressure at 78°C in the presence of P 2 O 5 for at least 12 h unless otherwise specified. Elemental analyses were obtained from Perkin-Elmer 2400 Elemental Analyzer. Sulfonic Acid 4-Formylphenyl Ester (3a-f). General Procedure Freshly distilled methanesulfonyl chloride (2.33 g, 20 mmol) was added to a solution of 4-hydroxybenzaldehyde (1.24 g, 10 mmol) in dry pyridine (10 ml) under ice bath. The reaction mixture was stirred at room temperature for 4 h and then poured into 10% HCl solution. Extraction with ethyl acetate, washing with saturated sodium bicarbonate and brine, drying with magnesium sulfate the mixture was concentrated under reduced pressure. Column chromatography of the residue on silica gel with 1 : 1 n-hexane/EtOAc as eluent gave 3a (1.3 g, 64%) as a light brown oil.
3b-f were obtained under the same condition. Methanelsulfonic Acid 4-Formylphenyl Ester (3a): Rf 0.55 (nhexane/EtOAcϭ1/1). mp: 62-63°C (lit. 16) 60-61°C Benzoic Acid 4-Formylphenyl Ester (5a-e). General Procedure Benzoyl chloride (2.8 g; 20 mmol) was added to a solution of 4-hydroxybenzaldehyde (1.24 g, 10 mmol) in dry pyridine (20 ml) under ice bath. The reaction mixture was stirred at room temperature for 8 h. Extraction with ethyl acetate, drying with magnesium sulfate the mixture was concentrated under reduced pressure. Column chromatography of the residue on silica gel with 1 : 1 n-hexane/EtOAc as eluent gave 5a (1.45 g, 64%) as a yellow crystal.
5b-e were obtained under the same condition. Benzoic Acid 4-Formylphenyl Ester (5a): Rf 0.46 (n-hexane/EtOAcϭ1/1 Hydroxycoumarin (2, 4a-f,  6a-e) . 17, 18) 2 , 25 mM NaCl, 1 mM DTT]. Products were separated on a 18% acrylamide/urea denaturing gel and quantified on a phosphoimager using ImageQuant software (AmershamPharmaciaBiotech). Strand transfer reactions were performed in triplicate in 96-well plates using 0.25 pmol of labeled U5A/U5B-2 double-stranded DNA substrate, 12 pmol of ST1/ST2 3Ј-biotinylated target DNA and 2 pmol of integrase in buffer A in a final volume of 40 ml. Radiolabeled reaction products were bound to Streptavidincoated magnetic beads (DynaL), washed twice in buffer B (PBS buffer supplemented with 0.025% tween 20 and 10 mg/ml BSA) and quantified on a beta radiation counter. Inhibition in the presence of drugs is expressed as the fractional product in percent of the control without drug.
Condensation of Benzaldehydes with 4-

